These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19808192)

  • 1. Quality indicators in cancer care: development and implementation for improved health outcomes in non-small-cell lung cancer.
    Lennes IT; Lynch TJ
    Clin Lung Cancer; 2009 Sep; 10(5):341-6. PubMed ID: 19808192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
    Ouwens MM; Hermens RR; Termeer RA; Vonk-Okhuijsen SY; Tjan-Heijnen VC; Verhagen AF; Hulscher MM; Marres HA; Wollersheim HC; Grol RP
    Cancer; 2007 Oct; 110(8):1782-90. PubMed ID: 17724680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic standards and perspectives for stage IV non-small cell lung cancer].
    Reck M; Rosell R; Tiemann M
    Onkologie; 2012; 35 Suppl 3():10-3. PubMed ID: 22678019
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality assessment in oncology.
    Albert JM; Das P
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):773-81. PubMed ID: 22445001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice guidelines for non-small cell lung cancer.
    Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
    [No Abstract]   [Full Text] [Related]  

  • 7. Consensus conference: multimodality management of early- and intermediate-stage non-small cell lung cancer.
    Bordoni R
    Oncologist; 2008 Sep; 13(9):945-53. PubMed ID: 18779538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality assurance].
    Flentje M; Hoffmann H; Huber RM
    Onkologie; 2012; 35 Suppl 3():14-6. PubMed ID: 22678020
    [No Abstract]   [Full Text] [Related]  

  • 9. Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC).
    Grossi F; Tiseo M
    Crit Rev Oncol Hematol; 2006 Jun; 58(3):221-30. PubMed ID: 16697211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a lung cancer care coordination program on timeliness of care.
    Alsamarai S; Yao X; Cain HC; Chang BW; Chao HH; Connery DM; Deng Y; Garla VN; Hunnibell LS; Kim AW; Obando JA; Taylor C; Tellides G; Rose MG
    Clin Lung Cancer; 2013 Sep; 14(5):527-34. PubMed ID: 23827516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using nurse navigation to improve timeliness of lung cancer care at a veterans hospital.
    Hunnibell LS; Rose MG; Connery DM; Grens CE; Hampel JM; Rosa M; Vogel DC
    Clin J Oncol Nurs; 2012 Feb; 16(1):29-36. PubMed ID: 22297004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of non-small cell lung cancer (NSCLC): a review.
    Tsim S; O'Dowd CA; Milroy R; Davidson S
    Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in the diagnosis and treatment of lung cancer.
    Gilligan D
    Int J Clin Pract; 1998; 52(5):330-4. PubMed ID: 9796565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)].
    Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M
    Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
    Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
    J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer.
    Freeman RK; Van Woerkom JM; Vyverberg A; Ascioti AJ
    Eur J Cardiothorac Surg; 2010 Jul; 38(1):1-5. PubMed ID: 20206544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Goss G; Paszat L; Newman TE; Evans WK; Browman G
    Cancer Prev Control; 1998 Feb; 2(1):32-9. PubMed ID: 9765764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the cost of lung cancer diagnosis and treatment in Canada: the POHEM model.
    Evans WK; Will BP; Berthelot JM; Wolfson MC
    Can J Oncol; 1995 Dec; 5(4):408-19. PubMed ID: 8770457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adopting integrated care pathways in non-small-cell lung cancer: from theory to practice.
    Fasola G; Rizzato S; Merlo V; Aita M; Ceschia T; Giacomuzzi F; Lugatti E; Meduri S; Morelli A; Rocco M; Tozzi V
    J Thorac Oncol; 2012 Aug; 7(8):1283-90. PubMed ID: 22653077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.